Abstract

Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. Clinical features depend on the immune status of the patient. Proper management of leprosy involves a comprehensive approach that includes diagnosis, treatment, rehabilitation, and prevention of disabilities.

• 1.   DNA of Jesus-Era Shrouded Man in Jerusalem Reveals Earliest Case of Leprosy, 2009.
• 2.   Fitness J, Tosh K, Hill A. Genetics of suceptibility to leprosy. Genes Inmmun. 2002;3:441---53.
• 3.   Britton WJ, Lockwood DN. Leprosy. The Lancet. 2004;363:1209-19.
• 4.   Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, et al. Comparative sequence analysis of Mycobacterium leprae and the new leprosycausing Mycobacterium lepromatosis. J Bacteriol. 2009;191:6067---74.
• 5.   Global leprosy situation. Weekly epidemiological record. Switzerland: World Health Organization; 2010. p. 337---48.
• 6.   Gulia A, Fried I, Massone C. New insights in the pathogenesis and genetics of leprosy. F1000 Medicine Reports. 2010;27:2.
• 7.   Shimoji Y, Ng V, Matsumura K, Fischetti V, Rambukkana A. A 21- kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. ProcNatlAcadSci U S A. 1999;96:9857---62.
• 8.   Alter A, Grant A, Abel L, Alcaïs A, Schurr E. Leprosy as a genetic disease. Mamm Genome. 2011;22:19-- -31.
• 9.   G. Weddell and E. Palmer, “The pathogenesis of leprosy. An experimental approach,” Leprosy Review, vol. 34, pp. 57–61, 1963.
• 10.   J. C. Pedley, “The nasal mucus in leprosy,” Leprosy Review, vol. 44, no. 1, pp. 33–35, 1973.
• 11.   K. Prabhakaran, E. B. Harris, and B. Randhawa, “Regulation by protein kinase of phagocytosis of Mycobacterium leprae by macrophages,” Journal of Medical Microbiology, vol. 49, no. 4, pp. 339–342, 2000.
• 12.   D. S. Ridley and W. H. Jopling, “Classification of leprosy according to immunity. A five-group system,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 34, no. 3, pp. 255–273, 1966.
• 13.   Ridley D, Jopling W. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255---73.
• 14.   Ooi WW, Srinivasan J. Leprosy and the peripheral nerve system: basic and clinical aspects. Muscle Nerve. 2004;30:393–409.
• 15.   Marahatta S, Bhattarai S, Paudel BH. Electrophysiological profles of leprosy neuropathy. Lepr Rev. 2017;88:373–80.
• 16.   Thappa DM, Sharma VK, Kaur S, Suri S. Radiological changes in hands and feet in disabled leprosy patients: a clinicoradiological correlation. Indian J Lepr. 1992;64:58–66.
• 17.   Ankad BS, Hombal A, Rao S, Naidu VM. Radiological changes in the hands and feet of leprosy patients with deformities. J ClinDiagn Res. 2011;5:703–7
• 18.   Maas M, Slim EJ, Heoksma AF, van der Kleij AJ, Akkerman EM, den Heeten GJ, et al. MR imaging of neuropathic feet in leprosy patients with suspected osteomyelitis. Int J Lepr Other Mycobact Dis. 2002;70(103):97
• 19.   Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet Lond Engl. 2010;375(9729):1920–37.
• 20.   Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loopmediated isothermal amplifcation of DNA. Nucleic Acids. 2000;28:E63

Data Sharing Statement

Funding